NMC.L

NMC Health Plc
NMC Health Plc - Additional Board Disclosures
16th April 2020, 09:05
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 8787J
NMC Health Plc
16 April 2020
 

 

NMC Health plc

("NMC PLC" or the "Company")

Additional board disclosures

London - April 16, 2020 - Further to the Company's announcement on April 14, 2020 regarding the appointments of Eli Chahin, Christopher Hall, Myles Halley and Philip Gore-Randall as non-executive Directors of the Company which took effect on April 11, 2020, the Company hereby discloses additional information for the purposes of LR 9.6.13R.

Christopher Hall was a director of MyBucks S.A. (listed on the Frankfurt Stock Exchange) from June 2017 to May 2019.

There is no further information required to be disclosed pursuant to LR 9.6.13R in relation to the appointment of the new non-executive Directors.

 

ENDS

NOTES TO EDITORS

Media Enquiries

Headland Consultancy

Susanna Voyle                  +44 7980 894 557

Stephen Malthouse           +44 7734 956 201

Henry Wallers                   +44 7876 562 436

nmchealthgroup@headlandconsultancy.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNKKABPFBKKOQD ]]>
TwitterFacebookLinkedIn